Bright Minds Biosciences Inc. logo

Bright Minds Biosciences Inc. (DRUG)

Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM)
$
76. 12
+1.89
+2.5461%
$
604.16M Market Cap
- P/E Ratio
- Div Yield
157,400 Volume
0 Eps
$ 74.23
Previous Close
Add Transaction
Day Range
73.11 79.2
Year Range
24.61 123.75
Want to track DRUG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Bright Minds Biosciences Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
Joseph Castro
Joseph Castro Nuveen LLC
8,329 $327,216.48 $634,564.85 $307,348.37 93.93%
Brian Baylis
Brian Baylis Bell Investment Advisors Inc.
6 $437.82 $458.15 $20.33 4.64%
Li Peng
Li Peng China Universal Asset Management Co. Ltd.
500 $36,485 $38,055 $1,570 4.3%
KJ
Ken Joseph Braidwel LLP
539,708 $35.75M $40.17M $4.42M 12.35%
GS
George Song Superstring Capital Management LP
13,311 $807,445.26 $1.01M $200,330.55 24.81%
IM
Ilko Menkov Vestal Point Capita LLP
492,319 $35.92M $37.92M $2M 5.56%
Twin Peaks Wealth Advisors LLC
Twin Peaks Wealth Advisors LLC TWIN PEAKS WEALTH ADVISORS, LLC
1 $73 $73.96 $0.96 1.32%
Mark Schafer
Mark Schafer Police & Firemen's Retirement System of New Jersey
2,036 $92,796.02 $150,440.04 $57,644.02 62.12%
BGI
B Group Inc. B Group Inc.
67,500 $4.93M $5.01M $85,050 1.73%
Yuen Man Lee
Yuen Man Lee Persistent Asset Partners Ltd.
2,310 $168,561 $177,766.05 $9,205.05 5.46%